Clinical Trials Logo

Clinical Trial Summary

Researchers in this study want to learn how the study drug BAY1817080 interacts with another drug called rosuvastatin (brand name: Crestor) and affects the way the body absorbs, distributes and excretes rosuvastatin in healthy adult male and female participants (drug-drug interaction study). The study drug BAY1817080 is a new drug under development with a goal to suppress pain and chronic cough. It works by binding to and blocking proteins related to pain in the body. Rosuvastatin is an approved and marketed drug to lower high levels of "bad" cholesterol (a waxy, fat-like substance found in blood). Both drugs interact with the same proteins (molecules) in the human body, and as a result, the study drug may affect the way rosuvastatin is taken up and used by the body when applied together. Participants in this study will be asked to visit the clinic 3 times over a period of 3 to 4 weeks. Each participant will receive rosuvastatin tablets twice with at least 11 days in between and the study drug tablets twice daily for 14 days. Blood samples will be taken from the participants to measure the blood levels of rosuvastatin.


Clinical Trial Description

The primary objective of the study is to investigate the influence of multiple doses of BAY1817080 on the pharmacokinetics of rosuvastatin given concomitantly. Secondary objective is to investigate the safety of BAY1817080. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04252300
Study type Interventional
Source Bayer
Contact
Status Completed
Phase Phase 1
Start date March 2, 2020
Completion date December 7, 2020

See also
  Status Clinical Trial Phase
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT01925638 - Effect of Ketoconazole on the Pharmacokinetics of Refametinib Phase 1
Completed NCT00621699 - Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects Phase 1
Completed NCT00442585 - S(+)-Ibuprofen Effects on Asprin Treated Volunteers Phase 1
Completed NCT00200759 - Drug Interactions and Bioavailability of Cranberry Phase 1
Active, not recruiting NCT06401863 - Shared Decision for Drug Interactions in Oral Anticoagulation N/A
Completed NCT00915746 - A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy Volunteers Phase 1
Completed NCT03748745 - A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects Phase 1
Completed NCT03324685 - A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen Phase 1
Completed NCT05433896 - Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions Phase 1
Recruiting NCT03307863 - Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy Phase 4
Completed NCT02706535 - A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential Phase 1
Completed NCT02147808 - A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects Phase 1
Completed NCT02097953 - Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin Phase 0
Completed NCT01364987 - Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy Volunteers Phase 1
Completed NCT00709982 - A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women. Phase 1
Completed NCT00810303 - Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2 Phase 1
Completed NCT02576366 - Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus Phase 4
Completed NCT02159326 - Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women Phase 1
Completed NCT01886209 - Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects Phase 1